Table 3.
‘Leave-one-out’ analysis for the health status sub-groups using continuous measures of lean mass.
| BIA |
DXA |
CT |
||||
|---|---|---|---|---|---|---|
| Heterogeneity I2 (no. of studies) | I2 after removing the most influential study | Heterogeneity I2 (no. of studies) | I2 after removing the most influential study | Heterogeneity I2 (no. of studies) | I2 after removing the most influential study | |
| Elderly | 46% (3) | 0% | 48% (5) | 25% | NA | – |
| Cancer | NA | – | NA | – | 76% (16) | 65% |
| Cardiovascular disease | NA | – | NA | – | 80% (6) | 76% |
| Liver disease | 0% (1)a | – | NA | – | 24% (9) | 0% |
| Lung disease | 42% (4) | 0% | NA | – | 32% (3) | 0% |
| Renal disease | 57% (7) | 47% | 78% (3) | 0% | 0% (2) | – |
| Other diseases | NA | – | NA | – | 63% (5) | 38% |
NA: only 1 or no study in sub-group.
BIA; bioelectrical impedance analysis; DXA, dual energy X-ray absorptiometry; CT, computerized tomography; NA, not available.
a
one study with two cohorts.